CAJ | 학술논문

目的：评价穴位贴敷联合埋线对肺胀的临床疗效。方法收集2011年1月－2013年5月深圳市宝安区人民医院中医科的肺胀患者122例，采用随机数表法将患者随机分为2组。对照组60例采用常规治疗，治疗组62例在对照组基础上加用穴位贴敷联合埋线治疗，均治疗4周。随访6个月，比较2组肺功能，包括第一秒用力呼气量（FEV1）和第一秒用力呼气量占用力肺活量百分率（FEV1/FVC）以及急性加重发生率和临床疗效。结果治疗组总有效率为98.4%（61/62），对照组为85.0%（51/60），2组比较差异有统计学意义（χ2＝5.592，P＜0.05）。治疗组急性加重发生率为8.1%（5/62），对照组为20.0%（12/60），2组比较差异无统计学意义（χ2＝3.358，P>0.05）。2组 FEV1（治疗组：71.58%±2.23%比59.98%±2.19%；t＝29.223，P＜0.01；对照组：66.99%±2.25%比61.03%±2.50%；t＝13.726，P＜0.01）和FEV1/FVC（治疗组：68.99%±1.33%比50.77%±1.45%；t＝72.914，P＜0.01；对照组：62.67%±1.47%比51.89%±1.88%；t=34.989，P＜0.01）均较治疗前显著升高，且治疗组改善优于对照组（FEV1：t＝13.726， P＜0.01；FEV1/FVC：t＝34.989，P＜0.01）。结论穴位贴敷联合埋线可改善肺胀患者肺功能，提高临床疗效。
목적：평개혈위첩부연합매선대폐창적림상료효。방법수집2011년1월－2013년5월심수시보안구인민의원중의과적폐창환자122례，채용수궤수표법장환자수궤분위2조。대조조60례채용상규치료，치료조62례재대조조기출상가용혈위첩부연합매선치료，균치료4주。수방6개월，비교2조폐공능，포괄제일초용력호기량（FEV1）화제일초용력호기량점용력폐활량백분솔（FEV1/FVC）이급급성가중발생솔화림상료효。결과치료조총유효솔위98.4%（61/62），대조조위85.0%（51/60），2조비교차이유통계학의의（χ2＝5.592，P＜0.05）。치료조급성가중발생솔위8.1%（5/62），대조조위20.0%（12/60），2조비교차이무통계학의의（χ2＝3.358，P>0.05）。2조 FEV1（치료조：71.58%±2.23%비59.98%±2.19%；t＝29.223，P＜0.01；대조조：66.99%±2.25%비61.03%±2.50%；t＝13.726，P＜0.01）화FEV1/FVC（치료조：68.99%±1.33%비50.77%±1.45%；t＝72.914，P＜0.01；대조조：62.67%±1.47%비51.89%±1.88%；t=34.989，P＜0.01）균교치료전현저승고，차치료조개선우우대조조（FEV1：t＝13.726， P＜0.01；FEV1/FVC：t＝34.989，P＜0.01）。결론혈위첩부연합매선가개선폐창환자폐공능，제고림상료효。
Objective To evaluate the efficacy of point application combined with catgut implantation at acupoint for lung-distention. Methods A total of 122 patients with lung-distension were randomized into a treatment group (62 patients) and a control group (60 patients). The patients in the control group received conventional treatment, and those in the treatment group were additionally treated with point application combined with catgut implantation at acupoint on the basis of the control group for 4 weeks. At 6 months follow-up, pulmonary function including the forced expiratory volume in first second (FEV1) and the percentage of FEV1 to forced vital capacity (FEV1/FVC), the total effective rate and acute exacerbation rate were compared in both groups. Results The total effective rate in the treatment group was significantly higher than that in the control group (98.4%vs. 85.0%;χ2=5.592, P<0.05). There were no significant difference in the acute exacerbation rate between the treatment group and the control group (8.1%vs. 20.0%;χ2=3.358, P>0.05).The FEV1 (treatment group: 71.58% ± 2.23% vs. 59.98% ± 2.19%, t=29.223, P<0.01; control group: 66.99% ± 2.25% vs. 61.03% ± 2.50%, t=13.726, P<0.01) and the FEV1/FVC (treatment group:68.99%± 1.33%vs. 50.77%± 1.45%, t=72.914, P<0.01; control group: 62.67% ± 1.47% vs. 51.89% ± 1.88%, t=34.989, P<0.01) after the treatment were significantly increased compared with before the treatment in both groups and such improvement in the treatment group was greater in the treatment group than that in the control group (FEV1: t=13.726, P<0.01;FEV1/FVC:t=34.989, P<0.01). Conclusion Point application combined with catgut implantation at acupoint can improve lung function and clinical effects in patients with lung-distention.